Published on 5 Feb 2024 on GuruFocus.com via Yahoo Finance
Director Heath Lukatch Sells 5,000 Shares of Vaxcyte Inc (PCVX)
On January 31, 2024, Heath Lukatch, a Director at Vaxcyte Inc, executed a sale of 5,000 shares of the company's stock. The transaction was filed with the SEC and can be found in detail through the following SEC Filing.
Warning! GuruFocus has detected 3 Warning Sign with PCVX.
Vaxcyte Inc, the company in question, is a biotechnology firm focused on the discovery, development, and commercialization of innovative vaccines. The company's pipeline includes candidates for a variety of infectious diseases, with an emphasis on improving health outcomes by enhancing vaccine efficacy and expanding coverage against challenging pathogens.